Market Research Logo

Windtree Therapeutics Inc (WINT) - Financial and Strategic SWOT Analysis Review

Windtree Therapeutics Inc (WINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company’s lead development product Aerosurf (lucinactant for inhalation), is an investigational combination drug/device product for the treatment of respiratory distress syndrome (RDS) in premature infants. Its technology platforms comprise a novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant, which is structurally similar to pulmonary surfactant, and proprietary drug delivery technologies for the delivery of aerosolized KL4 surfactant and other inhaled therapies. Windtree Therapeutics is headquartered in Warrington, Pennsylvania, the US.

Windtree Therapeutics Inc Key Recent Developments

Nov 14,2017: Windtree Therapeutics Reports Third Quarter 2017 Financial Results
Aug 21,2017: Windtree Therapeutics Reports Second Quarter 2017 Financial Results
May 15,2017: Windtree Therapeutics Reports First Quarter 2017 Financial Results and Provides Key Business Updates
Mar 31,2017: Windtree Therapeutics Reports Fourth Quarter 2016 Financial Results and Provides Key Business Updates

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Windtree Therapeutics Inc - Key Facts
Windtree Therapeutics Inc - Key Employees
Windtree Therapeutics Inc - Key Employee Biographies
Windtree Therapeutics Inc - Major Products and Services
Windtree Therapeutics Inc - History
Windtree Therapeutics Inc - Company Statement
Windtree Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Windtree Therapeutics Inc - Business Description
Windtree Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Windtree Therapeutics Inc - Strengths
Windtree Therapeutics Inc - Weaknesses
Windtree Therapeutics Inc - Opportunities
Windtree Therapeutics Inc - Threats
Windtree Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Windtree Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 14, 2017: Windtree Therapeutics Reports Third Quarter 2017 Financial Results
Aug 21, 2017: Windtree Therapeutics Reports Second Quarter 2017 Financial Results
May 15, 2017: Windtree Therapeutics Reports First Quarter 2017 Financial Results and Provides Key Business Updates
Mar 31, 2017: Windtree Therapeutics Reports Fourth Quarter 2016 Financial Results and Provides Key Business Updates
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Windtree Therapeutics Inc, Key Facts
Windtree Therapeutics Inc, Key Employees
Windtree Therapeutics Inc, Key Employee Biographies
Windtree Therapeutics Inc, Major Products and Services
Windtree Therapeutics Inc, History
Windtree Therapeutics Inc, Other Locations
Windtree Therapeutics Inc, Subsidiaries
Windtree Therapeutics Inc, Key Competitors
Windtree Therapeutics Inc, Ratios based on current share price
Windtree Therapeutics Inc, Annual Ratios
Windtree Therapeutics Inc, Annual Ratios (Cont...1)
Windtree Therapeutics Inc, Interim Ratios
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Windtree Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Windtree Therapeutics Inc, Performance Chart (2013 - 2017)
Windtree Therapeutics Inc, Ratio Charts
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report